CRG’s Ben Wessner sat down with Tom Hale, CEO of Oura, to discuss preventative care, the importance of sleep and the growing trend of individuals leveraging personal data to take charge of their own health and wellness.
Oura, headquartered in Oulu, Finland, is the creator of the Oura ring, a cutting-edge health biometric tracker renowned for its sleep applications.
Since CRG’s investment in February 2022 through Fund IV, Oura has seen remarkable growth, including the launch of its Gen 3 Horizon ring and several transformative partnerships. With a focus on empowering individuals to unlock their health potential, Oura continues to lead the way in wearable technology and personalized health insights.
Ben Wessner of CRG recently sat down with Tom Hale, CEO of Oura, to discuss the role of preventative care, the importance of sleep, and the rising trend of individuals using personal data to take control of their health and wellness. Learn more about Oura’s impact and Tom Hale’s vision for the future of wellness in our full interview.
Private debt investors are increasingly turning to the healthcare sector, attracted by the potential for higher returns compared to traditional direct lending strategies.
Private debt investors are increasingly targeting the healthcare sector, attracted by the potential for higher returns compared to traditional direct lending strategies. According to bfinance, healthcare lending funds have net internal rate of return (IRR) targets that are over 300 basis points higher than those of conventional direct lending funds.
This growing interest has led to the emergence of new healthcare-focused lending funds, with larger private debt managers entering a space previously dominated by smaller specialists. However, the sector presents unique challenges, including companies with low or negative cash flows, a significant proportion of unsponsored transactions, and complex deal structures.
Investors considering this niche should be aware of these complexities and the need for specialized expertise to navigate the sector effectively.
Luke Düster and Dr. Mark McClellan discuss the impact of the upcoming election on healthcare policy and investment. They highlight how election outcomes may shift legislative priorities and examine the role of private equity in healthcare.
Luke Düster and Dr. Mark McClellan delve into the potential effects of the upcoming election on healthcare policy and investment strategies. They discuss how changes in political leadership could shift legislative priorities, potentially impacting the broader healthcare landscape. A key focus of their conversation is the role of private equity in shaping the future of healthcare, particularly in driving innovation and expanding access.
They also highlight the growing movement toward consumer-driven healthcare, advocating for models that prioritize personalized, accessible, and patient-centered care. Additionally, the discussion touches on lessons from global healthcare systems, analyzing innovative practices and policies aimed at improving social well-being and enhancing overall system efficiency. This comprehensive dialogue sheds light on the intersection of policy, investment, and patient outcomes in an evolving healthcare environment.
Scott Li, a Partner at CRG, shares his thoughts on recent deal flow and how CRG has been able to establish a track record of successfully investing in the healthcare industry for more than two decades.
In the September 2024 edition of Haynes Boone's "Private Credit Connections," Scott Li, a Partner at CRG, shares insights into the firm's healthcare investment strategies. Li discusses the robust deal flow in 2024, attributing it to CRG's extensive industry experience and a well-developed pipeline that allows for long-term tracking of potential investments. He emphasizes CRG's exclusive focus on healthcare, which enables the firm to source proprietary deals with minimal competition. Li also highlights the importance of understanding a company's growth trajectory, management team, and market segment to provide value beyond capital. An example of this approach is CRG's $50 million loan to OrthAlign, facilitated by a longstanding relationship with its CEO.
For a more in-depth understanding of CRG's investment philosophy and strategies, you can download the full interview here:
The cost of US healthcare is going up but outcomes are getting worse – the venture community is at the heart of the search for innovative solutions, says Luke Düster, chief investment officer at CRG
With US healthcare costs rising and patient outcomes declining, the search for innovative solutions has become urgent. In an exclusive interview, Luke Düster, Chief Investment Officer at CRG, discusses how the venture community is stepping up to meet these challenges. Düster highlights the critical role of venture capital in driving breakthroughs that could transform the healthcare landscape and deliver better results for patients.
For an in-depth look at Düster’s insights on navigating these pressing issues:
CRG’s Ben Wessner sat down with Brad Olson, CEO of Sollis Health (“Sollis”), to discuss his career path and how Sollis has disrupted the delivery of urgent and emergency care through a membership-based, concierge model.
Ben Wessner of CRG recently sat down with Brad Olson, CEO of Sollis Health, to discuss his journey and how Sollis is transforming urgent and emergency care. Founded in 2016, Sollis Health operates on a membership-based, concierge model that redefines the patient experience. By staffing clinics with ER-boarded providers and equipping them with advanced lab and imaging technology, Sollis enables treatment of higher-acuity cases in a consumer-centric, high-touch environment.
Beyond in-clinic care, Sollis offers telemedicine, house calls, and care coordination services, creating a seamless healthcare experience for its 15,000+ members across 11 clinics in New York City, Los Angeles, San Francisco, and South Florida. CRG proudly partnered with Sollis in April 2024, supporting their mission to disrupt traditional care delivery and bring concierge healthcare to more communities.
Learn more about Sollis Health’s innovative approach and Brad Olson’s vision for the future in our full interview.
The U.S. is facing a worsening behavioral health crisis, highlighted by challenges exposed during the COVID-19 pandemic. In May 2023, U.S. Surgeon General Dr. Vivek Murthy described loneliness and isolation as a significant public health crisis, emphasizing the importance of human connection for healing and well-being.
The behavioral health crisis in the United States has reached a critical juncture, amplified by the challenges brought to light during the COVID-19 pandemic. This crisis manifests in many ways—both visible and hidden—and demands urgent, innovative solutions to address the growing mental health needs of individuals and communities.
In May 2023, U.S. Surgeon General Dr. Vivek Murthy highlighted the gravity of the issue, declaring, “Our epidemic of loneliness and isolation has been an underappreciated public health crisis that has harmed individual and societal health.” He emphasized the power of human connection as a vital, often overlooked resource for healing and well-being.
As the need for mental health solutions grows, so does the call to action for organizations and individuals to prioritize innovation and meaningful engagement to build healthier, more connected communities.
CRG’s Brian Englander sat down with Erik Timko, CEO of OrthAlign, to discuss the orthopedic surgery market, his career, and how his team is working to improve surgical outcomes for patients undergoing knee replacement and hip replacement surgeries.
Founded in 2004 and headquartered in Aliso Viejo, CA, OrthAlign is dedicated to improving surgical outcomes for patients undergoing knee and hip replacement surgeries through innovative medical device solutions.
OrthAlign’s technology provides real-time, precision guidance to orthopedic surgeons, enhancing the accuracy of joint replacement procedures. With over 300,000 patients served and the support of 30 peer-reviewed journals, OrthAlign continues to set the standard for precision in orthopedic care.
CRG’s investment in OrthAlign, completed in December 2023 through Fund V, supports the company’s mission to deliver better surgical outcomes and improve the quality of care for patients worldwide. Brian Englander of CRG recently sat down with Erik Timko, CEO of OrthAlign, to discuss his career and the advancements OrthAlign is making in the orthopedic surgery market.
CRG’s Sean Scanlan sat down with Wayne Cavanaugh, CEO of Family Care Center, to discuss the state of the behavioral health market and how Wanye and his team are working to address the mental health crisis by bringing critical therapy to more patients and expanding access to mental healthcare services.
Sean Scanlan of CRG recently spoke with Wayne Cavanaugh, CEO of Family Care Center (FCC), about the urgent need to address the mental health crisis and how FCC is expanding access to critical therapy services. Headquartered in Denver, Colorado, FCC operates a network of 25 outpatient mental health clinics, offering evidence-based treatments for conditions such as anxiety, depression, PTSD, and mood disorders through a fully integrated care model.
Since CRG’s investment in February 2023 as the first out of Fund V, FCC has opened nine new clinics, including expansions into Nashville, TN, and Austin, TX. Backed by Revelstoke Capital Partners, FCC continues to drive its mission to provide high-quality mental healthcare to underserved communities.
Learn more about FCC’s impact and Wayne Cavanaugh’s vision for addressing the mental health crisis in our full interview.
CRG’s Brian Englander sat down with Joe Catanese, CEO of Calyxo, to discuss the kidney stone market, his career, and how his team is working to change kidney stone treatment through its innovative technology, ultimately improving the quality of care for patients who suffer from kidney stones.
Brian Englander of CRG recently sat down with Joe Catanese, CEO of Calyxo, to discuss the evolving kidney stone market and how Calyxo’s innovative technology is improving patient care. Based in Pleasanton, California, Calyxo is a commercial-stage medical device company revolutionizing kidney stone removal procedures with its groundbreaking CVAC Aspiration System.
The CVAC system, the first steerable vacuum technology for kidney stone removal during ureteroscopy, simplifies the process by aspirating stone fragments after laser procedures. Since its FDA 510(k) clearance in May 2020, Calyxo has focused on increasing adoption of its technology and is preparing to launch its second-generation CVAC system in 2024.
CRG’s investment in Calyxo, made in January 2022 through Fund IV, supports the company’s mission to deliver better outcomes for kidney stone patients. Learn more about Calyxo’s innovative approach and Joe Catanese’s vision for the future in our full interview.
